Provider and pharmacist responses to warfarin drugedrug interaction alerts: A study of healthcare downstream of CPOE alerts

Journal of the American Medical Informatics Association

Volumn 18, Issue SUPPL. 1, 2011, Pages 45-50

  Miller, Allison M ^a   Boro, Maureen S ^b   Korman, Nancy E ^b   Ben Davoren, J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLUCONAZOLE; LEVOTHYROXINE; METRONIDAZOLE; MEVINOLIN; MULTIVITAMIN; PHENYTOIN; RIFAMPICIN; SULFAMETHOXAZOLE; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; COMPUTERIZED PROVIDER ORDER ENTRY; DEMOGRAPHY; DRUG INTERACTION; EMERGENCY CARE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHARMACIST; RETROSPECTIVE STUDY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; COMPUTER ASSISTED DRUG THERAPY; DRUG CONTRAINDICATION; HOSPITAL INFORMATION SYSTEM; INFANT; MEDICAL STAFF; MIDDLE AGED; PUBLIC HOSPITAL; REMINDER SYSTEM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; DRUG INTERACTIONS; DRUG THERAPY, COMPUTER-ASSISTED; HOSPITALS, VETERANS; HUMANS; INFANT; MALE; MEDICAL ORDER ENTRY SYSTEMS; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PHARMACISTS; REMINDER SYSTEMS; RETROSPECTIVE STUDIES; UNITED STATES; WARFARIN;

EID: 84857173399     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2011-000262     Document Type: Article

References (32)

1. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003;163:1409-16.
2. Wolfstadt JI, Gurwitz JH, Field TS, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 2008;23:451-8.
3. Ammenwerth E, Schnell-Inderst P, Machan C, et al. The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc 2008;15:585-600.
4. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006;13:138-47.
5. Grizzle AJ, Mahmood MH, Ko Y, et al. Reasons provided by prescribers when overriding drug-drug interaction alerts. Am J Manag Care 2007;13:573-8.
6. Lin CP, Nichol WP, Hoey P, et al. Approach for analysis of order check overrides in a computerized practitioner order entry system. AMIA Annu Symp Proc 2005:1033.
7. Lin CP, Payne TH, Nichol WP, et al. Evaluating clinical decision support systems: monitoring CPOE order check override rates in the Department of Veterans Affairs' Computerized Patient Record System. J Am Med Inform Assoc 2008;15:620-6.
8. Payne TH, Nichol WP, Hoey P, et al. Characteristics and override rates of order checks in a practitioner order entry system. Proc AMIA Symp 2002:602-6.
9. Hsieh TC, Kuperman GJ, Jaggi T, et al. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system. J Am Med Inform Assoc 2004;11:482-91.
10. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-31.
11. Snaith A, Pugh L, Simpson CR, et al. The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care. Am J Cardiovasc Drugs 2008;8:207-12.
12. Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm 2006;12:640-8.
13. Commission TJ. 2008 Hospital ational Patient Safety Goals. http://www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/08_hap_npsgs.htm (accessed 29 Jun 2008).
14. Judge J, Field TS, DeFlorio M, et al. Prescribers' responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc 2006;13:385-90.
15. Strom BL, Schinnar R, Bilker W, et al. Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAIDewarfarin co-prescribing as a test case. J Am Med Inform Assoc 2010;17:411-15.
16. Feldstein AC, Smith DH, Perrin N, et al. Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med 2006;166:1009-15.
17. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trialephase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988;11:1-11.
18. Chaitman BR, Thompson B, Wittry MD, et al. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators. J Am Coll Cardiol 1989;14:1159-65.
19. VHA Directive 2008-059, accredited to Michael J. Kussman (Under Secretary of Health). Adverse Drug Event Reporting and Monitoring. Washington, DC 20420, released 29 Sept 2008: http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=1773.
20. ® eAnswers [online]. 2009. Wolters Kluwer Health, Inc. http://online. factsandcomparisons.com (accessed 6 Feb 2009).
21. ® System [Internet database]. Greenwood Village, Colo: Thomson Micromedex. Updated periodically. http://www.thomsonhc.com (accessed 6 Feb 2009).
22. Chused AE, Kuperman GJ, Stetson PD. Alert override reasons: a failure to communicate. AMIA Annu Symp Proc 2008:111-15.
23. Singh H, Mani S, Espadas D, et al. Prescription errors and outcomes related to inconsistent information transmitted through computerized order entry: a prospective study. Arch Intern Med 2009;169:982-9.
24. van Doormaal JE, van den Bemt PM, Zaal RJ, et al. The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study. J Am Med Inform Assoc 2009;16: 816-25.
25. van der Sijs H, van Gelder T, Vulto A, et al. Understanding handling of drug safety alerts: a simulation study. Int J Med Inform 2010;79:361-9.
26. Lo HG, Matheny ME, Seger DL, et al. Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care. J Am Med Inform Assoc 2009;16:66-71.
27. Paterno MD, Maviglia SM, Gorman PN, et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc 2009;16:40-6.
28. Shah NR, Seger AC, Seger DL, et al. Improving override rates for computerized prescribing alerts in ambulatory care. AMIA Annu Symp Proc 2005:1110.
29. Greco PJ, Eisen M, Dixon-Williams S, et al. A Clinical Decision Support System to Reduce Prescribing of Warfarin-Interacting Antimicrobials. AMIA Annu Symp Proc 2009:867.
30. McCoy JA, Johnson D, Strom S, et al. User Response to Warfarin Initiation and Modification Dosing Support Tools. AMIA Annu Symp Proc 2009:958.
31. van Walraven C, Austin PC, Oake N, et al. The effect of hospitalization on oral anticoagulation control: a population-based study. Thromb Res 2007;119:705-14.
32. Hauta-Aho M, Tirkkonen T, Vahlberg T, et al. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Ann Med 2009;41:619-28.